Smita Bhatia
Directeur/Membre du Conseil chez St. Baldrick's Foundation
Profil
Smita Bhatia is currently working as a Director at St. Baldrick's Foundation, Director-Institute-Cancer Outcomes & Survivorship at The University of Alabama School of Medicine, and has a job at UAB Birmingham Comprehensive Cancer Center.
Postes actifs de Smita Bhatia
Sociétés | Poste | Début |
---|---|---|
The University of Alabama School of Medicine | Corporate Officer/Principal | - |
St. Baldrick's Foundation
St. Baldrick's Foundation Miscellaneous Commercial ServicesCommercial Services St. Baldrick's Foundation is the largest charity funder of childhood cancer research grants. The non-profit company is based in Monrovia, CA. The company's mission is to conquer kids cancer by supporting the most promising research to find cures and better treatments for all childhood cancers. The company supports virtually every institution with the expertise to treat kids with cancer across the world. St. Baldrick's ensures that children fighting cancer now and those diagnosed in the future will have access to the most cutting-edge treatment, by supporting every stage of research, from new ideas in the lab to the training of the next generation of researchers, to lifesaving clinical trials. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
St. Baldrick's Foundation
St. Baldrick's Foundation Miscellaneous Commercial ServicesCommercial Services St. Baldrick's Foundation is the largest charity funder of childhood cancer research grants. The non-profit company is based in Monrovia, CA. The company's mission is to conquer kids cancer by supporting the most promising research to find cures and better treatments for all childhood cancers. The company supports virtually every institution with the expertise to treat kids with cancer across the world. St. Baldrick's ensures that children fighting cancer now and those diagnosed in the future will have access to the most cutting-edge treatment, by supporting every stage of research, from new ideas in the lab to the training of the next generation of researchers, to lifesaving clinical trials. | Commercial Services |